Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving nuclear, medical, defense, and research end markets. This news page aggregates company press releases and third-party coverage so readers can follow how Mirion’s activities in radiation safety, science, and medicine develop over time.
Recent Mirion news has highlighted its role in the nuclear power sector and capital markets. The company announced a definitive agreement to acquire, and later the completion of the acquisition of, Paragon Energy Solutions, a provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors in the United States. News releases describe how Paragon’s systems and solutions are present in all nuclear reactors in North America and how the acquisition is intended to broaden Mirion’s portfolio for nuclear power customers, including SMRs, within the Mirion Nuclear & Safety group.
Investors and observers can also find updates on Mirion’s financial performance and financing activities. The company issues quarterly earnings press releases, such as its announcement of third quarter 2025 results, and provides guidance commentary. Additional news covers public offerings of Class A common stock, convertible senior notes offerings, and related financing steps to support acquisitions and general corporate purposes.
Beyond transactions and earnings, Mirion’s news flow includes strategic collaborations. A notable example is its partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA) to cooperate in radiation detection and measurement, including support for the IAEA’s Terrestrial Environmental Radiochemistry Laboratory. For ongoing insight into MIR stock-related developments, nuclear and medical segment updates, and regulatory or partnership announcements, readers can review this news feed regularly.
Mirion Technologies, Inc. (NYSE: MIR) announced an underwritten public offering of 9,786,153 shares of its Class A common stock at $8.75 per share, primarily by selling stockholders affiliated with Charterhouse Capital Partners. The company will not sell any securities or receive proceeds, but will cover certain costs associated with the offering. Closing is expected on March 7, 2023, pending customary conditions. The offering is made under a shelf registration previously approved by the SEC on November 28, 2022. Jefferies serves as the sole bookrunner.
Mirion Technologies has announced a public offering of 9,786,153 shares of its Class A common stock by certain selling stockholders affiliated with Charterhouse Capital Partners. Importantly, Mirion will not receive any proceeds from this offering and will cover the associated costs, excluding underwriting discounts. This offering is subject to market conditions and may not be completed as anticipated. Jefferies is the sole bookrunner for the offering, which utilizes an effective shelf registration statement declared by the SEC on November 28, 2022. Investors are advised to review the registration statement for detailed information.
Mirion Technologies (NYSE:MIR) announced a $150 million investment from T. Rowe Price Investment Management to acquire shares at $8.75 each, totaling 17,142,857 shares. The transaction will close on February 23, 2023. Mirion plans to use approximately $125 million to pay down debt, aiming for a net leverage ratio of approximately 3.1x by year-end 2023. The company also raised its adjusted free cash flow guidance for 2023, now projected between $58 million and $78 million, mostly due to lower interest expenses.
Janus International Group (NYSE: JBI) has appointed David Vanevenhoven as Chief Accounting Officer, effective February 20, 2023. Vanevenhoven, who has over 15 years of experience in accounting and M&A auditing, will directly report to CFO Anselm Wong. He previously served as Global Controller at Mirion Technologies (NYSE: MIR), where he managed multiple acquisitions and a successful SPAC merger. His role at Janus aims to enhance financial reporting and internal controls, positioning the company for continued growth in the self-storage sector. This strategic appointment follows the release of Janus's annual financial results for 2022.
Mirion Technologies, Inc. (MIR) reported a 22.6% revenue increase in Q4 2022, reaching $217.9 million, compared to $177.8 million in Q4 2021. The GAAP net loss was $159.7 million, translating to a loss per share of $0.85. Adjusted EBITDA stood at $56.4 million with adjusted EPS of $0.11. For 2023, the company anticipates revenue growth of 6% to 9% and adjusted EBITDA between $172 million and $182 million. Despite goodwill impairments of $156.6 million, Mirion's order backlog grew to $737.4 million. Management expresses optimism for continued growth driven by healthy end markets and a solid backlog.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Citi’s 2023 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation is scheduled for 1:50 PM ET on Tuesday, February 21, 2023. A live webcast will be available at Mirion’s investor relations page, with an archived version accessible within twelve hours post-event.
About Mirion: Headquartered in Atlanta, GA, Mirion provides detection, measurement, and analysis solutions across nuclear, defense, medical, and research sectors, employing around 2,800 individuals globally.
Mirion Technologies (NYSE: MIR) will release its financial results for Q4 and fiscal year 2022 on February 14, 2023. A conference call will follow at 10:00 am ET to discuss these results. Participants can join the call by dialing 1-877-407-9208 or 1-201-493-6784, and a live webcast will be available at Mirion's investor website. A telephonic replay will be accessible until February 28, 2023, with details for accessing it provided. Mirion is a leader in detection and monitoring solutions in various end markets including nuclear and medical sectors, employing roughly 2,800 staff across 13 countries.
Mirion Technologies, through its subsidiary Sun Nuclear, has designated Scripps Health as a Patient Safety Center of Excellence. This recognition highlights Scripps' leadership in Quality Management and Medical Physics in Radiation Therapy, with a focus on improving patient safety. Treating approximately 2,700 new patients annually in San Diego, Scripps aims to standardize and automate Quality Management workflows, enhancing efficiency. By leveraging Sun Nuclear's solutions, Scripps will guide other U.S. medical physics departments, thereby contributing to advancements in treatment protocols.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the CJS Securities 23rd Annual New Ideas for the New Year Conference on January 11, 2023, at 3:45 PM ET. The presentation will be available via live webcast on their website, with an archive accessible within twelve hours post-event. Mirion specializes in detection, measurement, and monitoring solutions across various sectors, employing around 2,800 people globally.
Mirion Technologies, Inc. (NYSE: MIR) has entered a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. to Salona Global Medical Device Corporation for $5 million in cash and up to $3 million in deferred cash payments based on asset performance. These assets generated approximately $18 million in revenue with a gross margin of 30% in the last year. The deal is expected to close on December 31, 2022, allowing Mirion to focus on its core mission regarding ionizing radiation.